Article

Metaproteomics reveals potential signatures of disease-specific alterations in the gut microbial proteolytic events in inflammatory bowel disease

2020-07-02

Abstract excerpt

<title>Abstract</title> <p>Background: Proteolysis regulation allows gut microbes to respond rapidly to dynamic intestinal environments by fast degradation of misfolded proteins and activation of regulatory proteins. However, alterations of gut microbial proteolytic signatures under complex disease status such as inflammatory bowel disease (IBD, including Crohn’s disease (CD) and ulcerative colitis (UC)) have no...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4d8094f8-db82-56b5-b643-bf7e08d6f60f
DOI: 10.21203/rs.3.rs-38249/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metaproteomics reveals potential signatures of disease-specific alterations in the gut microbial proteolytic events in inflammatory bowel diseaseDOI 10.21203/rs.3.rs-38249/v1Read

A microbiome meta-transcriptomics pipeline identifies a novel human neutrophil elastase inhibitor that protects the colonic epithelial barrierSemantic proximity Read

The Interplay Between Genetic Risk Factors and Proteolytic Dysregulation in the Pathophysiology of Inflammatory Bowel Disease.Semantic proximity Read

The human gut metaproteomics: insights on wet and dry workflowsSemantic proximity Read

Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions.Semantic proximity Read

A Metaproteomic Approach to Study Human-Microbial Ecosystems at the Mucosal Luminal InterfaceSemantic proximity Read

Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel diseaseSemantic proximity Read

Proteomics and metabolomics in inflammatory bowel disease.Semantic proximity Read

Comparative Genomic and Functional Profiling of ECM-Targeting Enzymes in <i>Bacteroides</i> , a Key Genus of the Human Gut MicrobiomeSemantic proximity Read

A metaproteomics-based meta study of samples from patients with inflammatory bowel disease identifies potential markers for diagnosis and therapy monitoringSemantic proximity Read

Community-based peptidomic clustering reveals pathogen-specific proteolytic signatures in woundsSemantic proximity Read

In silico degradomics reveals disease- and endotype-specific alterations in the joint tissue landscapeSemantic proximity Read

Ultra-sensitivity metaproteomics redefines the gut “dark metaproteome”, uncovering host-microbiome interactions and drug targets in intestinal inflammatory diseasesSemantic proximity Read